Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome After Transcatheter and Surgical Aortic Valve Replacement: Insight From the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A

Background— The effect of preoperative mitral regurgitation (MR) on clinical outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) is controversial. This study sought to examine the impact of moderate and severe MR on outcomes after TAVR and surgical aortic valve replacement (SAVR). Methods and Results— Data were drawn from the randomized Placement of Aortic Transcatheter Valve (PARTNER) Trial cohort A patients with severe, symptomatic aortic stenosis undergoing either TAVR (n=331) or SAVR (n=299). Both TAVR and SAVR patients were dichotomized according to the degree of preoperative MR (moderate/severe versus none/mild). At baseline, moderate or severe MR was reported in 65 TAVR patients (19.6%) and 63 SAVR patients (21.2%). At 30 days, among survivors who had isolated SAVR/TAVR, moderate/severe MR had improved in 25 SAVR patients (69.4%) and 30 TAVR patients (57.7%), was unchanged in 10 SAVR patients (27.8%) and 19 TAVR patients (36.5%), and worsened in 1 SAVR patient (2.8%) and 4 TAVR patients (5.8%; all P=NS). Mortality at 2 years was higher in SAVR patients with moderate or severe MR than in those with mild or less MR (49.8% versus 28.1%; adjusted hazard ratio, 1.73; 95% confidence interval, 1.01–2.96; P=0.04). In contrast, MR severity at baseline did not affect mortality in TAVR patients (37.0% versus 32.7%, moderate/severe versus none/mild; hazard ratio, 1.14; 95% confidence interval, 0.72–1.78; P=0.58; P for interaction=0.05). Conclusions— Both TAVR and SAVR were associated with a significant early improvement in MR in survivors. However, moderate or severe MR at baseline was associated with increased 2-year mortality after SAVR but not after TAVR. TAVR may be a reasonable option in selected patients with combined aortic and mitral valve disease. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00530894.

[1]  F. Santini,et al.  Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. , 2013, International journal of cardiology.

[2]  G. Bloomfield,et al.  Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3]  D. Wood,et al.  Clinical ResearchInterventional CardiologyTranscatheter Aortic Valve Replacement: Outcomes of Patients With Moderate or Severe Mitral Regurgitation , 2012 .

[4]  G. Gerosa,et al.  Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  P. Leprince,et al.  Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.

[6]  T. Huber,et al.  Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients , 2012 .

[7]  T. Athanasiou,et al.  Aortic valve replacement for aortic stenosis in patients with concomitant mitral regurgitation: should the mitral valve be dealt with? , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  Antonio Colombo,et al.  One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: The European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve , 2011, Circulation.

[9]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[10]  W. Keeling,et al.  Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011 .

[11]  A. Gillinov,et al.  Echocardiographic predictors for persistent functional mitral regurgitation after aortic valve replacement in patients with aortic valve stenosis. , 2010, The American journal of cardiology.

[12]  Samin K. Sharma,et al.  Evidence based management of patients undergoing PCI. Conclusion. , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  P. Serruys,et al.  Changes in mitral regurgitation after transcatheter aortic valve implantation , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  P. Lancellotti,et al.  Republished review: Mitral regurgitation in patients with aortic stenosis undergoing valve replacement , 2009, Postgraduate Medical Journal.

[15]  T. Sundt,et al.  Management of moderate functional mitral regurgitation at the time of aortic valve replacement: is concomitant mitral valve repair necessary? , 2009, The Journal of thoracic and cardiovascular surgery.

[16]  E. Olalla,et al.  Incidence, associated factors and evolution of non-severe functional mitral regurgitation in patients with severe aortic stenosis undergoing aortic valve replacement. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[17]  G. Vlahakes,et al.  Changes in mitral regurgitation after replacement of the stenotic aortic valve. , 2008, The Annals of thoracic surgery.

[18]  David B Matchar,et al.  Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. , 2007, JAMA.

[19]  J. Borer,et al.  The epidemiology of valvular heart disease: a growing public health problem. , 2006, Heart failure clinics.

[20]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[21]  M. Ruel,et al.  Natural History and Predictors of Outcome in Patients With Concomitant Functional Mitral Regurgitation at the Time of Aortic Valve Replacement , 2006, Circulation.

[22]  W. Baumgartner,et al.  Aortic Valve Replacement and Concomitant Mitral Valve Regurgitation in the Elderly: Impact on Survival and Functional Outcome , 2005, Circulation.

[23]  R. Levine,et al.  American Society of Echocardiography: recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography , 2003 .

[24]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[25]  D. Metz,et al.  Factors determining early improvement in mitral regurgitation after aortic valve replacement for aortic valve stenosis: A transthioracic and transesophageal prospective study , 2003, Clinical cardiology.

[26]  J. Jayne,et al.  Improvement in mitral regurgitation after aortic valve replacement. , 1997, The American journal of cardiology.

[27]  I Kronzon,et al.  Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. , 1990, The American journal of cardiology.

[28]  S. Shaughnessy,et al.  Do No Harm: Health Systems’ Duty to Promote Clinician Well-Being , 2022, American Journal of Hospital Medicine.